Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy

This publication has 23 references indexed in Scilit:

• Determination of Ki‐67 defined growth fraction by monoclonal antibody MIB‐i in formalin‐fixed, paraffin‐embedded prostatic cancer tissues
  The Prostate, 1995
• A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate Cancer
  Journal of Urology, 1995
• Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki‐67 and PCNA expression
  The Prostate, 1995
• Evaluation of Ki‐67 Monoclonal Antibody as Prognostic Indicator for Prostatic Carcinoma
  British Journal of Urology, 1993
• A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team
  Archives of Family Medicine, 1993
• Ki‐67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models
  Cell Proliferation, 1993
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections
  The Journal of Pathology, 1992
• Pathological and clinical associations of Ki‐67 defined growth fractions in human prostatic carcinoma
  The Prostate, 1992
• Monoclonal antibody Ki‐67: its use in histopathology
  Histopathology, 1990
• Growth fractions in human prostatic carcinoma determined by Ki‐67 immunostaining
  The Journal of Pathology, 1988